Legend Capital was among the investors in the synthetic biology-derived materials producer’s fourth round, which helped lift its total funding to over $100m.

China-based synthetic biology technology developer Tidetron has raised hundreds of millions of yuan (RMB100m = $15.7m) in a series A-plus round featuring Legend Capital, the venture capital firm formed by conglomerate Legend Holdings, 36Kr reported yesterday.

Venture capital firm IDG Capital led the round, which included Unity Ventures and ZhenFund and which took Tidetron’s total funding to over $100m. It reportedly represents the company’s fourth funding round.

Founded in 2021, Tidetron is working on raw materials derived from biologically fermented…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn